e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Pulmonary infections and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
N-acetylcysteine and dexamethasone in the prevention of respiratory complications in acute pancreatitis
S. Chooklin, R. Vatseba (Lviv, Ukraine)
Source:
Annual Congress 2007 - Pulmonary infections and inflammation
Session:
Pulmonary infections and inflammation
Session type:
Electronic Poster Discussion
Number:
470
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Chooklin, R. Vatseba (Lviv, Ukraine). N-acetylcysteine and dexamethasone in the prevention of respiratory complications in acute pancreatitis. Eur Respir J 2007; 30: Suppl. 51, 470
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
Pathogenesis and ways of prophylactic of ARDS in acute pancreatitis
Source: Eur Respir J 2002; 20: Suppl. 38, 282s
Year: 2002
N-acetylcysteine for the treatment of acute exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 374s
Year: 2002
Ambroxol for the prevention of acute upper respiratory disease
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Pathogenic aspects of pulmonary complications in acute pancreatitis patients
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Pathogenic aspects of pulmonary complications in acute pancreatitis patients
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Oral nutritional supplementation during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 593s
Year: 2002
NIV in acute and chronic cardiac diseases
Source: School Course 2014 - Noninvasive ventilation: basic concepts
Year: 2014
Cardiovascular effects of high dose N-acetylcysteine in severe pneumonia-induced sepsis
Source: Eur Respir J 2003; 22: Suppl. 45, 452s
Year: 2003
The management of acute asthma with and without the administration of aminophylline
Source: Eur Respir J 2006; 28: Suppl. 50, 314s
Year: 2006
Antioxidants and anticytokines in the prevention of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 108s
Year: 2004
N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 795-798
Year: 2003
N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 865
Year: 2003
Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure
Source: Annual Congress 2009 - Respiratory physiotherapy assessment
Year: 2009
Efficacy of surfactant-BL in treatment ARDS in patients with severe inhalation injury
Source: Eur Respir J 2006; 28: Suppl. 50, 345s
Year: 2006
Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome
Source: Eur Respir J 2003; 21: 720-727
Year: 2003
Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Acute effect of erdosteine on preventing recurrence of exacerbation in COPD patients after hospital discharge
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Year: 2012
Acute and chronic respiratory infections
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017
Acute and chronic respiratory infections
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept